These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36167755)

  • 1. Prognostic impact of the coexistence of hepato-renal dysfunction and frailty in patients with heart failure.
    Noda T; Kamiya K; Hamazaki N; Nozaki K; Ichikawa T; Yamashita M; Uchida S; Maekawa E; Terada T; Reed JL; Yamaoka-Tojo M; Matsunaga A; Ako J
    J Cardiol; 2023 Feb; 81(2):215-221. PubMed ID: 36167755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of impaired hepato-renal function and liver fibrosis in patients admitted for acute heart failure.
    Kawahira M; Tamaki S; Yamada T; Watanabe T; Morita T; Furukawa Y; Kawasaki M; Kikuchi A; Kawai T; Seo M; Nakamura J; Kayama K; Kimura T; Ueda K; Sakamoto D; Kogame T; Ito S; Chang Y; Fukunami M
    ESC Heart Fail; 2021 Apr; 8(2):1274-1283. PubMed ID: 33472273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of change in hepato-renal function and cardiac rehabilitation on mortality in patients with heart failure.
    Noda T; Kamiya K; Hamazaki N; Nozaki K; Uchida S; Ueno K; Miki T; Hotta K; Maekawa E; Terada T; Reed JL; Yamaoka-Tojo M; Matsunaga A; Ako J
    J Cardiol; 2024 Dec; 84(6):355-361. PubMed ID: 38917873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver dysfunction assessed by model for end-stage liver disease excluding INR (MELD-XI) scoring system predicts adverse prognosis in heart failure.
    Abe S; Yoshihisa A; Takiguchi M; Shimizu T; Nakamura Y; Yamauchi H; Iwaya S; Owada T; Miyata M; Sato T; Suzuki S; Oikawa M; Kobayashi A; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Suzuki H; Saitoh S; Takeishi Y
    PLoS One; 2014; 9(6):e100618. PubMed ID: 24955578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart Transplant and Hepato-Renal Dysfunction: The Model of End-Stage Liver Disease Excluding International Normalized Ratio as a Predictor of Postoperative Outcomes.
    Loforte A; Fiorentino M; Gliozzi G; Mariani C; Folesani G; Suarez SM; Russo A; Masetti M; Potena L; Pacini D
    Transplant Proc; 2019 Nov; 51(9):2962-2966. PubMed ID: 31607616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of the MELD-XI score in patients undergoing cardiac resynchronization therapy.
    Saito Y; Nakai T; Ikeya Y; Kogawa R; Otsuka N; Wakamatsu Y; Kurokawa S; Ohkubo K; Nagashima K; Okumura Y
    ESC Heart Fail; 2022 Apr; 9(2):1080-1089. PubMed ID: 34983080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model for end-stage liver disease excluding international normalized ratio (MELD-XI) score predicts heart transplant outcomes: Evidence from the registry of the United Network for Organ Sharing.
    Deo SV; Al-Kindi SG; Altarabsheh SE; Hang D; Kumar S; Ginwalla MB; ElAmm CA; Sareyyupoglu B; Medalion B; Oliveira GH; Park SJ
    J Heart Lung Transplant; 2016 Feb; 35(2):222-7. PubMed ID: 26527533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of cardio-hepatic-skeletal muscle syndrome in patients with heart failure.
    Noda T; Kamiya K; Hamazaki N; Nozaki K; Ichikawa T; Nakamura T; Yamashita M; Uchida S; Maekawa E; Reed JL; Yamaoka-Tojo M; Matsunaga A; Ako J
    Sci Rep; 2021 Feb; 11(1):3715. PubMed ID: 33580115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired hepato-renal function defined by the MELD XI score as prognosticator in acute heart failure.
    Biegus J; Zymliński R; Sokolski M; Siwołowski P; Gajewski P; Nawrocka-Millward S; Poniewierka E; Jankowska EA; Banasiak W; Ponikowski P
    Eur J Heart Fail; 2016 Dec; 18(12):1518-1521. PubMed ID: 27709804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of the modified model for end-stage liver disease (MELD) score including albumin in acute heart failure.
    Liao S; Lu X; Cheang I; Zhu X; Yin T; Yao W; Zhang H; Li X
    BMC Cardiovasc Disord; 2021 Mar; 21(1):128. PubMed ID: 33750318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Hepatorenal Function By Modified Model for End-stage Liver Disease (MELD) Score in Patients Undergoing Tricuspid Annuloplasty.
    Chen Y; Liu YX; Seto WK; Wu MZ; Yu YJ; Lam YM; Au WK; Chan D; Sit KY; Ho LM; Tse HF; Yiu KH
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30006492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of liver biopsy with MELD-XI scores for post-transplant outcome prediction in patients with advanced heart failure and suspected liver dysfunction.
    Farr M; Mitchell J; Lippel M; Kato TS; Jin Z; Ippolito P; Dove L; Jorde UP; Takayama H; Emond J; Naka Y; Mancini D; Lefkowitch JH; Schulze PC
    J Heart Lung Transplant; 2015 Jul; 34(7):873-82. PubMed ID: 25851466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model for End-stage Liver Disease excluding INR (MELD-XI) score in critically ill patients: Easily available and of prognostic relevance.
    Wernly B; Lichtenauer M; Franz M; Kabisch B; Muessig J; Masyuk M; Hoppe UC; Kelm M; Jung C
    PLoS One; 2017; 12(2):e0170987. PubMed ID: 28151948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of the model for end-stage liver disease excluding INR score (MELD-XI) in patients with adult congenital heart disease.
    Konno R; Tatebe S; Sugimura K; Satoh K; Aoki T; Miura M; Suzuki H; Yamamoto S; Sato H; Terui Y; Miyata S; Adachi O; Kimura M; Saiki Y; Shimokawa H
    PLoS One; 2019; 14(11):e0225403. PubMed ID: 31743362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model for End-Stage Liver Disease Excluding INR (MELD-XI) score is associated with hemodynamic impairment and predicts mortality in critically ill patients.
    Wernly B; Lichtenauer M; Vellinga N; Boerma C; Ince C; Kelm M; Jung C
    Eur J Intern Med; 2018 May; 51():80-84. PubMed ID: 29572092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model of End-Stage Liver Disease-eXcluding International Normalized Ratio (MELD-XI) Scoring System to Predict Outcomes in Patients Who Undergo Left Ventricular Assist Device Implantation.
    Critsinelis A; Kurihara C; Volkovicher N; Kawabori M; Sugiura T; Manon M; Wang S; Civitello AB; Morgan JA
    Ann Thorac Surg; 2018 Aug; 106(2):513-519. PubMed ID: 29626453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatorenal dysfunction identifies high-risk patients with acute heart failure: insights from the RELAX-AHF trial.
    Biegus J; Demissei B; Postmus D; Cotter G; Davison BA; Felker GM; Filippatos G; Gimpelewicz C; Greenberg B; Metra M; Severin T; Teerlink JR; Voors AA; Ponikowski P
    ESC Heart Fail; 2019 Dec; 6(6):1188-1198. PubMed ID: 31568696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of hepatorenal function following transcatheter edge-to-edge mitral valve repair.
    Tanaka T; Kavsur R; Spieker M; Iliadis C; Metze C; Horn P; Sugiura A; Baldus S; Kelm M; Nickenig G; Pfister R; Westenfeld R; Becher MU
    Clin Res Cardiol; 2021 Dec; 110(12):1947-1956. PubMed ID: 34254179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of impaired hepato-renal function assessed by the MELD-XI score in patients undergoing percutaneous mitral valve repair.
    Spieker M; Hellhammer K; Wiora J; Klose S; Zeus T; Jung C; Saeed D; Horn P; Kelm M; Westenfeld R
    Catheter Cardiovasc Interv; 2019 Mar; 93(4):699-706. PubMed ID: 30328258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of hepatorenal function in patients undergoing transcatheter tricuspid valve repair.
    Tanaka T; Kavsur R; Sugiura A; Vogelhuber J; Öztürk C; Weber M; Tiyerili V; Zimmer S; Nickenig G; Becher MU
    Sci Rep; 2021 Jul; 11(1):14420. PubMed ID: 34257395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.